Wockhardt Limited has informed the Exchange regarding a press release dated October 16, 2024, titled - Wockhardt files fast-acting Insulin Aspart injection (ASPARAPIDTM) with DCGI; strengthens commitment to diabetes management .
Wockhardt Limited has informed the Exchange regarding a press release dated October 16, 2024, titled - Wockhardt files fast-acting Insulin Aspart injection (ASPARAPIDTM) with DCGI; strengthens commitment to diabetes management .